Stevens Capital Management LP Sells 217 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Stevens Capital Management LP cut its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 17.8% during the third quarter, Holdings Channel.com reports. The firm owned 999 shares of the biotechnology company’s stock after selling 217 shares during the period. Stevens Capital Management LP’s holdings in Axon Enterprise were worth $399,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Menard Financial Group LLC boosted its stake in shares of Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after purchasing an additional 24 shares in the last quarter. PFG Investments LLC lifted its position in Axon Enterprise by 0.6% during the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after acquiring an additional 25 shares during the last quarter. Gladstone Institutional Advisory LLC lifted its position in Axon Enterprise by 1.6% during the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after acquiring an additional 26 shares during the last quarter. Mather Group LLC. lifted its position in Axon Enterprise by 3.7% during the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after acquiring an additional 27 shares during the last quarter. Finally, King Luther Capital Management Corp lifted its position in Axon Enterprise by 0.3% during the third quarter. King Luther Capital Management Corp now owns 10,474 shares of the biotechnology company’s stock valued at $4,185,000 after acquiring an additional 34 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 25,811 shares of Axon Enterprise stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total value of $9,287,830.24. Following the sale, the president now owns 228,166 shares in the company, valued at $82,103,253.44. This trade represents a 10.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Patrick W. Smith sold 47,314 shares of Axon Enterprise stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $400.07, for a total transaction of $18,928,911.98. Following the completion of the sale, the chief executive officer now owns 2,983,802 shares in the company, valued at approximately $1,193,729,666.14. This trade represents a 1.56 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 137,921 shares of company stock worth $63,093,907. 6.10% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Robert W. Baird increased their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $500.00 to $700.00 in a report on Tuesday. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, JMP Securities raised their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $460.33.

Axon Enterprise Stock Up 0.3 %

AXON stock opened at $689.78 on Friday. The firm has a market cap of $52.60 billion, a PE ratio of 178.24, a P/E/G ratio of 14.74 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm’s fifty day moving average is $510.40 and its 200 day moving average is $389.53. Axon Enterprise, Inc. has a one year low of $231.83 and a one year high of $695.94.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.